Outcomes
macrosomia, LGA, birth injury, CGM-measured
NEONATAL HYPOGLYCEMIA, NEONATAL RESPIRATORY DISTRESS SYNDROME, GESTATIONAL HYPERTENSION, SECONDARY, HYPERBILIRUBINEMIA, PRETERM DELIVERY, PREECLAMPSIA
The primary outcome was CGM-measured TIR at 8 weeks after enrollment. The secondary outcomes included HbA1c level before delivery; GWG; birth weight of the newborn; CGM-measured GV; insulin treatment; adverse pregnancy outcomes including gestational hypertension, preeclampsia, rate of cesarean, preterm delivery, macrosomia (birthweight ≥4 kg), large or small for gestational age (birthweight percentile >90th or <10th, LGA or SGA) and composite neonatal outcome (birth injury, neonatal hypoglycemia, hyperbilirubinemia, neonatal respiratory distress syndrome, and neonatal intensive care unit admission >24 h).